As of 2025-07-07, the Relative Valuation of Utah Medical Products Inc (UTMD) is 137.13 USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.44 USD, the upside of Utah Medical Products Inc based on Relative Valuation is 134.7%.
The range of the Relative Valuation is 124.52 - 148.05 USD.
| Range | Selected | |
| Trailing P/E multiples | 34.3x - 34.7x | 34.5x |
| Forward P/E multiples | 28.8x - 29.9x | 29.4x |
| Fair Price | 124.52 - 148.05 | 137.13 |
| Upside | 113.1% - 153.3% | 134.7% |
| Date | P/E |
| 2025-07-03 | 13.69 |
| 2025-07-02 | 13.47 |
| 2025-07-01 | 13.44 |
| 2025-06-30 | 13.33 |
| 2025-06-27 | 13.54 |
| 2025-06-26 | 13.22 |
| 2025-06-25 | 13.03 |
| 2025-06-24 | 13.05 |
| 2025-06-23 | 12.86 |
| 2025-06-20 | 12.57 |
| 2025-06-18 | 12.58 |
| 2025-06-17 | 12.64 |
| 2025-06-16 | 12.90 |
| 2025-06-13 | 12.92 |
| 2025-06-12 | 13.44 |
| 2025-06-11 | 13.36 |
| 2025-06-10 | 13.42 |
| 2025-06-09 | 13.35 |
| 2025-06-06 | 13.16 |
| 2025-06-05 | 13.13 |
| 2025-06-04 | 13.10 |
| 2025-06-03 | 13.12 |
| 2025-06-02 | 12.82 |
| 2025-05-30 | 12.90 |
| 2025-05-29 | 12.79 |
| 2025-05-28 | 12.66 |
| 2025-05-27 | 12.81 |
| 2025-05-23 | 12.59 |
| 2025-05-22 | 12.57 |
| 2025-05-21 | 12.49 |
| 2025-05-20 | 12.70 |
| 2025-05-19 | 12.76 |
| 2025-05-16 | 12.91 |
| 2025-05-15 | 12.85 |
| 2025-05-14 | 12.74 |
| 2025-05-13 | 12.82 |
| 2025-05-12 | 12.65 |
| 2025-05-09 | 12.56 |
| 2025-05-08 | 12.62 |
| 2025-05-07 | 12.63 |
| 2025-05-06 | 12.54 |
| 2025-05-05 | 12.25 |
| 2025-05-02 | 12.34 |
| 2025-05-01 | 12.23 |
| 2025-04-30 | 12.12 |
| 2025-04-29 | 12.30 |
| 2025-04-28 | 12.23 |
| 2025-04-25 | 12.27 |
| 2025-04-24 | 12.38 |
| 2025-04-23 | 12.47 |